DNA methylation profiles of the brain-derived neurotrophic factor (BDNF) gene as a potent diagnostic biomarker in major depression.
Major depression, because of its recurring and life-threatening nature, is one of the top 10 diseases for global disease burden. Major depression is still diagnosed on the basis of clinical symptoms in patients. The search for specific biological markers is of great importance to advance the method...
Guardado en:
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Public Library of Science (PLoS)
2011
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/17bed39f3e224b739727bc1ed01d1e20 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:17bed39f3e224b739727bc1ed01d1e20 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:17bed39f3e224b739727bc1ed01d1e202021-11-18T06:47:03ZDNA methylation profiles of the brain-derived neurotrophic factor (BDNF) gene as a potent diagnostic biomarker in major depression.1932-620310.1371/journal.pone.0023881https://doaj.org/article/17bed39f3e224b739727bc1ed01d1e202011-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21912609/pdf/?tool=EBIhttps://doaj.org/toc/1932-6203Major depression, because of its recurring and life-threatening nature, is one of the top 10 diseases for global disease burden. Major depression is still diagnosed on the basis of clinical symptoms in patients. The search for specific biological markers is of great importance to advance the method of diagnosis for depression. We examined the methylation profile of 2 CpG islands (I and IV) at the promoters of the brain-derived neurotrophic factor (BDNF) gene, which is well known to be involved in the pathophysiology of depression. We analyzed genomic DNA from peripheral blood of 20 Japanese patients with major depression and 18 healthy controls to identify an appropriate epigenetic biomarker to aid in the establishment of an objective system for the diagnosis of depression. Methylation rates at each CpG unit was measured using a MassArray® system (SEQUENOM), and 2-dimensional hierarchical clustering analyses were undertaken to determine the validity of these methylation profiles as a diagnostic biomarker. Analyses of the dendrogram from methylation profiles of CpG I, but not IV, demonstrated that classification of healthy controls and patients at the first branch completely matched the clinical diagnosis. Despite the small number of subjects, our results indicate that classification based on the DNA methylation profiles of CpG I of the BDNF gene may be a valuable diagnostic biomarker for major depression.Manabu FuchikamiShigeru MorinobuMasahiro SegawaYasumasa OkamotoShigeto YamawakiNorio OzakiTakeshi InoueIchiro KusumiTsukasa KoyamaKounosuke TsuchiyamaTakeshi TeraoPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 6, Iss 8, p e23881 (2011) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medicine R Science Q |
| spellingShingle |
Medicine R Science Q Manabu Fuchikami Shigeru Morinobu Masahiro Segawa Yasumasa Okamoto Shigeto Yamawaki Norio Ozaki Takeshi Inoue Ichiro Kusumi Tsukasa Koyama Kounosuke Tsuchiyama Takeshi Terao DNA methylation profiles of the brain-derived neurotrophic factor (BDNF) gene as a potent diagnostic biomarker in major depression. |
| description |
Major depression, because of its recurring and life-threatening nature, is one of the top 10 diseases for global disease burden. Major depression is still diagnosed on the basis of clinical symptoms in patients. The search for specific biological markers is of great importance to advance the method of diagnosis for depression. We examined the methylation profile of 2 CpG islands (I and IV) at the promoters of the brain-derived neurotrophic factor (BDNF) gene, which is well known to be involved in the pathophysiology of depression. We analyzed genomic DNA from peripheral blood of 20 Japanese patients with major depression and 18 healthy controls to identify an appropriate epigenetic biomarker to aid in the establishment of an objective system for the diagnosis of depression. Methylation rates at each CpG unit was measured using a MassArray® system (SEQUENOM), and 2-dimensional hierarchical clustering analyses were undertaken to determine the validity of these methylation profiles as a diagnostic biomarker. Analyses of the dendrogram from methylation profiles of CpG I, but not IV, demonstrated that classification of healthy controls and patients at the first branch completely matched the clinical diagnosis. Despite the small number of subjects, our results indicate that classification based on the DNA methylation profiles of CpG I of the BDNF gene may be a valuable diagnostic biomarker for major depression. |
| format |
article |
| author |
Manabu Fuchikami Shigeru Morinobu Masahiro Segawa Yasumasa Okamoto Shigeto Yamawaki Norio Ozaki Takeshi Inoue Ichiro Kusumi Tsukasa Koyama Kounosuke Tsuchiyama Takeshi Terao |
| author_facet |
Manabu Fuchikami Shigeru Morinobu Masahiro Segawa Yasumasa Okamoto Shigeto Yamawaki Norio Ozaki Takeshi Inoue Ichiro Kusumi Tsukasa Koyama Kounosuke Tsuchiyama Takeshi Terao |
| author_sort |
Manabu Fuchikami |
| title |
DNA methylation profiles of the brain-derived neurotrophic factor (BDNF) gene as a potent diagnostic biomarker in major depression. |
| title_short |
DNA methylation profiles of the brain-derived neurotrophic factor (BDNF) gene as a potent diagnostic biomarker in major depression. |
| title_full |
DNA methylation profiles of the brain-derived neurotrophic factor (BDNF) gene as a potent diagnostic biomarker in major depression. |
| title_fullStr |
DNA methylation profiles of the brain-derived neurotrophic factor (BDNF) gene as a potent diagnostic biomarker in major depression. |
| title_full_unstemmed |
DNA methylation profiles of the brain-derived neurotrophic factor (BDNF) gene as a potent diagnostic biomarker in major depression. |
| title_sort |
dna methylation profiles of the brain-derived neurotrophic factor (bdnf) gene as a potent diagnostic biomarker in major depression. |
| publisher |
Public Library of Science (PLoS) |
| publishDate |
2011 |
| url |
https://doaj.org/article/17bed39f3e224b739727bc1ed01d1e20 |
| work_keys_str_mv |
AT manabufuchikami dnamethylationprofilesofthebrainderivedneurotrophicfactorbdnfgeneasapotentdiagnosticbiomarkerinmajordepression AT shigerumorinobu dnamethylationprofilesofthebrainderivedneurotrophicfactorbdnfgeneasapotentdiagnosticbiomarkerinmajordepression AT masahirosegawa dnamethylationprofilesofthebrainderivedneurotrophicfactorbdnfgeneasapotentdiagnosticbiomarkerinmajordepression AT yasumasaokamoto dnamethylationprofilesofthebrainderivedneurotrophicfactorbdnfgeneasapotentdiagnosticbiomarkerinmajordepression AT shigetoyamawaki dnamethylationprofilesofthebrainderivedneurotrophicfactorbdnfgeneasapotentdiagnosticbiomarkerinmajordepression AT norioozaki dnamethylationprofilesofthebrainderivedneurotrophicfactorbdnfgeneasapotentdiagnosticbiomarkerinmajordepression AT takeshiinoue dnamethylationprofilesofthebrainderivedneurotrophicfactorbdnfgeneasapotentdiagnosticbiomarkerinmajordepression AT ichirokusumi dnamethylationprofilesofthebrainderivedneurotrophicfactorbdnfgeneasapotentdiagnosticbiomarkerinmajordepression AT tsukasakoyama dnamethylationprofilesofthebrainderivedneurotrophicfactorbdnfgeneasapotentdiagnosticbiomarkerinmajordepression AT kounosuketsuchiyama dnamethylationprofilesofthebrainderivedneurotrophicfactorbdnfgeneasapotentdiagnosticbiomarkerinmajordepression AT takeshiterao dnamethylationprofilesofthebrainderivedneurotrophicfactorbdnfgeneasapotentdiagnosticbiomarkerinmajordepression |
| _version_ |
1718424400183689216 |